TrialTheScientificWorldJournal2013

rHuEPO hyporesponsiveness and related high dosages are associated with hyperviscosity in maintenance hemodialysis patients.

Mehtap Erkmen Uyar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.